SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-116837
Filing Date
2011-04-29
Accepted
2011-04-29 07:32:40
Documents
6
Period of Report
2011-04-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17209
2 PRESS RELEASE ISSUED APRIL 29, 2011 REGARDING EARNINGS FOR FIRST QUARTER 2011 dex991.htm EX-99.1 345700
3 CERTAIN SUPPLEMENTAL INFORMATION NOT INCLUDED IN THE PRESS RELEASE dex992.htm EX-99.2 363026
4 PRESS RELEASE ISSUED APRIL 27, 2011 dex993.htm EX-99.3 8637
6 GRAPHIC g176035ex99_1.jpg GRAPHIC 8138
7 GRAPHIC g176035g67b75.jpg GRAPHIC 6398
  Complete submission text file 0001193125-11-116837.txt   756182
Mailing Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100 908-423-4840
Merck & Co. Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 11790923
SIC: 2834 Pharmaceutical Preparations